I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.430
-0.050 (-3.38%)
At close: Jul 19, 2024, 4:00 PM
1.380
-0.050 (-3.50%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
I-Mab Employees
I-Mab had 220 employees as of December 31, 2023. The number of employees decreased by 158 or -41.80% compared to the previous year.
Employees
220
Change
-158
Growth
-41.80%
Revenue / Employee
$17,723
Profits / Employee
-$939,668
Market Cap
110.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 220 | -158 | -41.80% |
| Dec 31, 2021 | 378 | 150 | 65.79% |
| Dec 31, 2020 | 228 | 43 | 23.24% |
| Dec 31, 2019 | 185 | 51 | 38.06% |
| Dec 31, 2018 | 134 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Augmedix | 1,430 |
| Karyopharm Therapeutics | 325 |
| Adagene | 174 |
| BrainsWay | 134 |
| aTyr Pharma | 59 |
| Elutia | 54 |
| Journey Medical | 41 |
| Regulus Therapeutics | 30 |
IMAB News
- 7 days ago - I-Mab Announces Leadership Transitions - PRNewsWire
- 6 weeks ago - I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers - PRNewsWire
- 2 months ago - I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024 - GlobeNewsWire
- 2 months ago - I-Mab to Participate at the Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - I-MAB Filed 2023 Annual Report on Form 20-F - PRNewsWire
- 3 months ago - I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire
- 3 months ago - I-Mab Announces Closing of the Divestiture of Business Operations in China - PRNewsWire
- 4 months ago - I-Mab Reports Full Year 2023 Financial Results and Business Update - PRNewsWire